Activist investor Starboard Value opposes Bristol-Myers-Celgene deal

Activist investor Starboard Value said Thursday it intends to use its stake in Bristol-Myers Squibb to oppose the drugmaker’s $74 billion acquisition of Celgene.

Source link

Leave a Comment

At least 20 dead in blasts at sports center in Afghan capitalQuick pregnancy safe after stillbirth, study finds